Updated:
Think.Health Ventures
Think.Health Ventures is a specialist private equity firm focused exclusively on healthcare technology, operating from Cambridge, Germany. Founded to bridge...
Think.Health Ventures
Think.Health Ventures is a specialist private equity firm focused exclusively on healthcare technology, operating from Cambridge, Germany. Founded to bridge the gap between clinical innovation and scalable commercial models, the firm deploys capital across early-stage and growth phases. The investment mandate centers on digital health, medical devices, and healthcare services — areas where the team's operating background in clinical practice and health system management provides a structural advantage over generalist tech investors. The firm targets companies that have moved beyond concept validation into initial clinical adoption or regulatory clearance. Think.Health Ventures typically leads or co-leads seed and Series A rounds, reserving significant follow-on capacity for select portfolio companies through growth stages. Deployment spans Germany, the broader DACH region, and select Western European markets. Publicly confirmed investments include digital therapeutics platforms, remote patient monitoring systems, and AI-driven diagnostic tools, though specific portfolio company names remain closely held outside limited partner communications. Team size and total assets under management are not publicly disclosed. The firm maintains a lean partnership structure consistent with an operator-led investment model. In May 2024, the firm marked its participation in a syndicate backing a German digital health platform achieving DiGA listing — the national reimbursement pathway for prescribed digital applications (per public record, May 2024). The team's proximity to the Charité and Heidelberg clinical ecosystems shapes the sourcing pipeline, as does the broader Berlin-Cambridge health tech corridor that has produced multiple exited European digital health companies. Think.Health Ventures stands apart from German multi-stage funds by operating as a pure healthcare-sector vehicle — no software, no fintech, no climate. When a firm says no to everything else, the yes carries conviction that generalist managers cannot replicate on a single deal. That sector focus, combined with the reimbursement-first investment lens that DiGA and DVG regulation now enable, makes this a structurally distinct mandate in European health tech.
General information
Firm type
Private Equity
Year founded
2015
Location
Region
Europe
Country
Germany
City
Cambridge
Corporate office
Cambridge, Germany
Principals
Dr. Florian Kainzinger
Managing Partner & Founder
Dr. Michael Ruoff
Partner
Nils Bottler
Venture Partner
Sector focus
Frequently asked questions
Who runs investment decisions at Think.Health Ventures?
Dr. Florian Kainzinger, the Managing Partner and Founder, leads investment decisions. He draws on over 20 years of healthcare management experience, including his prior role as CEO of Labor Berlin, where he ran a 500-employee diagnostic lab organization across 12 sites. The firm lists Dr. Michael Ruoff as Partner and Nils Bottler as Venture Partner, both with more than a decade of investment experience.
Is Think.Health Ventures structured as a single-family office or does it operate more like a venture firm?
Think.Health Ventures functions as a specialized asset manager deploying its own capital alongside co-investors on a deal-by-deal basis. The firm maintains a network of individual investors and family offices who invest alongside it. It does not operate a traditional blind-pool fund with a fixed fund life, which gives it flexibility on deployment timing.
What investment stages does Think.Health Ventures typically target?
The firm targets early-stage and growth healthcare companies. Its website states typical investment sizes from €500,000 to €10 million. Portfolio companies span from seed-stage ventures to expansion-stage businesses across digital health, medical devices, diagnostics, and biotechnology.
Which sectors does Think.Health Ventures explicitly avoid?
Think.Health Ventures focuses exclusively on healthcare — spanning digital healthcare, medical technologies, health service providers, life sciences, pharmaceuticals, and biotechnology. The firm does not invest outside healthcare, and its portfolio reveals no exposure to generalist technology, consumer, or industrial sectors.
Where does Think.Health Ventures source its deals?
Deal flow appears concentrated in the DACH region — Germany, Austria, and Switzerland. Portfolio companies like Petleo, which supports over 1,000 veterinary practices across the DACH region and Luxembourg, reflect the firm's geographic center of gravity. The firm also backs select companies in broader Europe and the US, such as the California-based biotech startup Earli.
Does Think.Health Ventures participate in fund commitments or only direct deals?
The firm operates exclusively through direct equity investments in healthcare companies. Its website lists no fund-of-funds commitments, and its co-investor model relies on bringing family offices and individual investors into specific deals rather than participating as a limited partner in third-party funds.
What is Think.Health Ventures' known posture on co-investments alongside external GPs?
The firm actively brings in co-investors from its network of individual investors and family offices to participate alongside its own capital in specific deals. It does not present itself as a limited partner in external GP-led funds. Its model is to identify healthcare ventures, invest directly, and open the opportunity to aligned co-investors.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: